Does Rallies show Form 4 insider transactions for IVVD?

Yes. Rallies tracks IVVD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is IVVD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IVVD. It does not provide personalized investment advice.

IVVD (Invivyd, Inc. Common Stock) Stock Analysis - Insider Trades

Invivyd, Inc. Common Stock (IVVD) is a publicly traded Healthcare sector company. As of May 21, 2026, IVVD trades at $1.13 with a market cap of $332.91M and a P/E ratio of -3.52. IVVD moved +4.33% today. Year to date, IVVD is -57.25%; over the trailing twelve months it is +34.70%. Its 52-week range spans $0.35 to $3.07. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces IVVD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading IVVD stock inside the company?

Recent IVVD insider activity includes Allen Robert D. III sold 19.39K, Green Julie sold 20.96K, Duke William E. sold 20.96K, Lee Timothy Edward sold 20.96K, and Andersen Jill sold 34.94K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

IVVD Key Metrics

Key financial metrics for IVVD
Metric	Value
Price	$1.13
Market Cap	$332.91M
P/E Ratio	-3.52
EPS	$-0.30
Dividend Yield	0.00%
52-Week High	$3.07
52-Week Low	$0.35
Volume	1.68K
Avg Volume	0
Revenue (TTM)	$53.43M
Net Income	$-52.49M
Gross Margin	0.00%

Recent IVVD Insider Trades

Allen Robert D. III sold 19.39K (~$30.60K) on Feb 18, 2026.
Green Julie sold 20.96K (~$33.08K) on Feb 18, 2026.
Duke William E. sold 20.96K (~$33.08K) on Feb 18, 2026.
Lee Timothy Edward sold 20.96K (~$33.08K) on Feb 18, 2026.
Andersen Jill sold 34.94K (~$55.13K) on Feb 18, 2026.

Latest IVVD News

Invivyd’s Q1 Revenue Drops to $13.7M, 22% PEMGARDA Growth Fails to Offset EPS Miss — May 14, 2026
Invivyd Q1 PEMGARDA Revenue Climbs 22% to $13.7M with $204.2M Cash — May 14, 2026
Invivyd CSO Unveils mAb Platform Addressing Virus Variation and Scalability at Vaccine Congress — Mar 30, 2026
Invivyd Completes VYD2311 Trial Enrollment, PEMGARDA Sales Rise 31% — Mar 6, 2026
Invivyd Q4 Revenue Rises 25% to $17.2M; Cash Hits $226.7M — Mar 5, 2026

IVVD Analyst Consensus

3 analysts cover IVVD: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.

Common questions about IVVD

Who is trading IVVD stock inside the company?: Recent IVVD insider activity includes Allen Robert D. III sold 19.39K, Green Julie sold 20.96K, Duke William E. sold 20.96K, Lee Timothy Edward sold 20.96K, and Andersen Jill sold 34.94K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for IVVD?: Yes. Rallies tracks IVVD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is IVVD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IVVD. It does not provide personalized investment advice.